Human epidermal growth factor receptor 2 (HER2) overexpression (HER2+) is frequently (15–20%) detected in breast cancer [100], and patients with HER2+ breast cancer have an increased risk of developing BrMs [101]. The gene discussed is ERBB2; the disease is breast carcinoma.